150 related articles for article (PubMed ID: 25763370)
1. Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines.
Parmar MB; Aliabadi HM; Mahdipoor P; Kucharski C; Maranchuk R; Hugh JC; Uludağ H
Front Bioeng Biotechnol; 2015; 3():14. PubMed ID: 25763370
[TBL] [Abstract][Full Text] [Related]
2. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
[TBL] [Abstract][Full Text] [Related]
3. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
4. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
[TBL] [Abstract][Full Text] [Related]
5. Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA.
Raja MAG; Katas H; Amjad MW
Asian J Pharm Sci; 2019 Sep; 14(5):497-510. PubMed ID: 32104477
[TBL] [Abstract][Full Text] [Related]
6. siRNA therapy in cutaneous T-cell lymphoma cells using polymeric carriers.
Sahin B; Fife J; Parmar MB; Valencia-Serna J; Gul-Uludağ H; Jiang X; Weinfeld M; Lavasanifar A; Uludağ H
Biomaterials; 2014 Nov; 35(34):9382-94. PubMed ID: 25128374
[TBL] [Abstract][Full Text] [Related]
7. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells.
Parmar MB; K C RB; Löbenberg R; Uludağ H
Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931
[TBL] [Abstract][Full Text] [Related]
8. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
9. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
10. Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC.
Ye Z; Abdelmoaty MM; Curran SM; Dyavar SR; Kumar D; Alnouti Y; Coulter DW; Podany AT; Singh RK; Vetro JA
Noncoding RNA; 2022 Jan; 8(1):. PubMed ID: 35076584
[TBL] [Abstract][Full Text] [Related]
11. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.
Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA
Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972
[TBL] [Abstract][Full Text] [Related]
12. Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
Meenakshi Sundaram DN; Kc RB; Uludağ H
J Gene Med; 2022 Jun; 24(6):e3419. PubMed ID: 35373897
[TBL] [Abstract][Full Text] [Related]
13. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.
Aliabadi HM; Maranchuk R; Kucharski C; Mahdipoor P; Hugh J; Uludağ H
J Control Release; 2013 Nov; 172(1):219-228. PubMed ID: 23994345
[TBL] [Abstract][Full Text] [Related]
14. Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy.
Li Y; Ding J; Xu X; Shi R; Saw PE; Wang J; Chung S; Li W; Aljaeid BM; Lee RJ; Tao W; Teng L; Farokhzad OC; Shi J
Nano Lett; 2020 Jul; 20(7):4857-4863. PubMed ID: 32479088
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
16. Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation.
Taniguchi K; Momiyama N; Ueda M; Matsuyama R; Mori R; Fujii Y; Ichikawa Y; Endo I; Togo S; Shimada H
Anticancer Res; 2008; 28(3A):1559-63. PubMed ID: 18630511
[TBL] [Abstract][Full Text] [Related]
17. Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.
Aliabadi HM; Landry B; Mahdipoor P; Hsu CY; Uludağ H
Eur J Pharm Biopharm; 2012 May; 81(1):33-42. PubMed ID: 22311298
[TBL] [Abstract][Full Text] [Related]
18. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of palmitic acid-conjugated DsiRNA for colon cancer in a mouse subcutaneous tumor model.
Kubo T; Nishimura Y; Hatori Y; Akagi R; Mihara K; Yanagihara K; Seyama T
Chem Biol Drug Des; 2019 Apr; 93(4):570-581. PubMed ID: 30560565
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.
Liu M; Zhang Y; Liao Y; Chen Y; Pan Y; Tian H; Zhan Y; Liu D
Cancer Biother Radiopharm; 2015 Aug; 30(6):233-9. PubMed ID: 26132704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
